RecruitingNCT07382583

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer


Sponsor

M.D. Anderson Cancer Center

Enrollment

270 participants

Start Date

Feb 12, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria18

  • Unaffected women
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must be premenopausal
  • Must not have a prior history of EC or complex atypical hyperplasia
  • Must provide written, informed consent
  • No physical, psychological, or cognitive impairments that would preclude participation in an interview as determined by the PI or study team member
  • Affected women
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must have a prior history of EC or complex atypical hyperplasia
  • Must provide written, informed consent
  • No physical, psychological, or cognitive impairments that would preclude participation in an interview as determined by the PI or study team member
  • Healthcare Providers
  • Physicians or advanced practice providers (physician assistants, nurse practitioners) from Family Medicine, Obstetrics \& Gynecology, Internal Medicine, or Endocrinology
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written, informed consent for qualitative interviews

Exclusion Criteria1

  • N/A

Interventions

OTHERSurvey using a questionnaire

Patient Preference Utility Assessment and Questionnaires


Locations(2)

The Harris Health System (LBJ)

Houston, Texas, United States

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07382583


Related Trials